|
|
|
|

|
Home >> Investor Relations >> Corporate Governance >> Insider Transactions
Insider Transactions
| Date |
Name |
Title |
Type |
Shares Traded  |
Price Range |
| Jul 22, 2008 |
licholai gregory p |
Officer |
Sell |
15,000 |
15.00 |
| Jul 22, 2008 |
licholai gregory p |
Officer |
Option Execute |
15,000 |
0.64 |
| Jun 5, 2007 |
barris peter j |
Beneficial Owner (10% or more) |
Option Execute |
15,077 |
6.38 |
| Jun 5, 2007 |
kramlich c richard |
Beneficial Owner (10% or more) |
Option Execute |
15,077 |
6.38 |
| Jun 5, 2007 |
new enterprise associates 11 lp |
Beneficial Owner (10% or more) |
Option Execute |
15,077 |
6.38 |
| Jun 5, 2007 |
newhall charles w iii |
Beneficial Owner (10% or more) |
Option Execute |
15,077 |
6.38 |
| Jun 5, 2007 |
perry mark w |
Beneficial Owner (10% or more) |
Option Execute |
15,077 |
6.38 |
| Jun 5, 2007 |
barkas alexander e |
Director |
Option Execute |
15,119 |
6.38 |
| Jun 5, 2007 |
prospect venture partners ii lp |
Beneficial Owner (10% or more) |
Option Execute |
15,119 |
6.38 |
| Jul 27, 2007 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
17,800 |
11.26 - 11.50 |
| Jul 27, 2007 |
topper james n |
Director |
Buy |
17,800 |
11.26 - 11.50 |
| Mar 3, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
18,426 |
9.83 - 10.00 |
| Mar 3, 2008 |
topper james n |
Director |
Buy |
18,426 |
9.83 - 9825.00 |
| Mar 15, 2013 |
crowley john f |
Officer |
Acquisition (Non Open Market) |
18,506 |
3.49 |
| Nov 4, 2009 |
barer sol j |
Director |
Buy |
20,000 |
4.13 |
| Jun 17, 2011 |
crowley john f |
Officer |
Buy |
20,000 |
6.04 |
| Jan 2, 2008 |
crowley john f |
Officer |
Option Execute |
20,000 |
0.64 |
| Apr 24, 2008 |
palling david |
Officer |
Option Execute |
20,000 |
0.64 |
| Dec 2, 2008 |
patterson matthew r |
Officer |
Option Execute |
20,098 |
0.64 |
| Mar 6, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
22,146 |
9.90 - 10.18 |
|
|
Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
|
|
|
|
|
|
|